Jade Biosciences (JBIO) Competitors $7.78 +0.29 (+3.87%) As of 09/4/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock JBIO vs. CRMD, ATAI, SYRE, CRON, PRAX, NUVB, PHAR, MLYS, ORIC, and IOVAShould you be buying Jade Biosciences stock or one of its competitors? The main competitors of Jade Biosciences include CorMedix (CRMD), atai Life Sciences (ATAI), Spyre Therapeutics (SYRE), Cronos Group (CRON), Praxis Precision Medicines (PRAX), Nuvation Bio (NUVB), Pharming Group (PHAR), Mineralys Therapeutics (MLYS), Oric Pharmaceuticals (ORIC), and Iovance Biotherapeutics (IOVA). These companies are all part of the "pharmaceutical products" industry. Jade Biosciences vs. Its Competitors CorMedix atai Life Sciences Spyre Therapeutics Cronos Group Praxis Precision Medicines Nuvation Bio Pharming Group Mineralys Therapeutics Oric Pharmaceuticals Iovance Biotherapeutics CorMedix (NASDAQ:CRMD) and Jade Biosciences (NASDAQ:JBIO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Do analysts recommend CRMD or JBIO? CorMedix presently has a consensus target price of $17.33, indicating a potential upside of 35.42%. Jade Biosciences has a consensus target price of $16.00, indicating a potential upside of 105.66%. Given Jade Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Jade Biosciences is more favorable than CorMedix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorMedix 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.86Jade Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, CRMD or JBIO? CorMedix has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500. Comparatively, Jade Biosciences has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Do institutionals & insiders believe in CRMD or JBIO? 34.2% of CorMedix shares are held by institutional investors. 5.3% of CorMedix shares are held by company insiders. Comparatively, 24.9% of Jade Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor CRMD or JBIO? In the previous week, CorMedix had 9 more articles in the media than Jade Biosciences. MarketBeat recorded 12 mentions for CorMedix and 3 mentions for Jade Biosciences. CorMedix's average media sentiment score of 0.94 beat Jade Biosciences' score of 0.77 indicating that CorMedix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorMedix 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Jade Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CRMD or JBIO more profitable? CorMedix has a net margin of 42.11% compared to Jade Biosciences' net margin of 0.00%. CorMedix's return on equity of 42.73% beat Jade Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets CorMedix42.11% 42.73% 34.19% Jade Biosciences N/A -51.96%-47.65% Which has preferable earnings and valuation, CRMD or JBIO? CorMedix has higher revenue and earnings than Jade Biosciences. Jade Biosciences is trading at a lower price-to-earnings ratio than CorMedix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorMedix$43.47M21.98-$17.93M$0.7517.07Jade BiosciencesN/AN/A-$69.63M-$30.33-0.26 SummaryCorMedix beats Jade Biosciences on 13 of the 16 factors compared between the two stocks. Get Jade Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for JBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JBIO vs. The Competition Export to ExcelMetricJade BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$244.54M$3.13B$5.76B$9.85BDividend YieldN/A2.28%6.67%4.51%P/E Ratio-0.2620.8975.9926.43Price / SalesN/A458.96546.94119.09Price / CashN/A44.5237.0558.92Price / Book0.089.9310.916.06Net Income-$69.63M-$53.38M$3.29B$266.28M7 Day Performance-1.52%0.63%0.18%-0.32%1 Month Performance-2.02%6.31%6.26%3.44%1 Year PerformanceN/A11.63%51.54%23.11% Jade Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JBIOJade Biosciences2.7056 of 5 stars$7.78+3.9%$16.00+105.7%N/A$244.54MN/A-0.2620CRMDCorMedix3.5413 of 5 stars$13.99+1.9%$17.33+23.9%+123.0%$1.02B$121.48M18.6530Positive NewsShort Interest ↑ATAIatai Life Sciences3.5121 of 5 stars$4.83+1.9%$11.25+132.9%+273.8%$1.02B$310K-7.0080SYRESpyre Therapeutics2.7793 of 5 stars$17.06+2.9%$53.40+213.0%-39.3%$1.00B$890K-5.0273News CoverageInsider TradeCRONCronos Group1.7084 of 5 stars$2.55-1.5%N/A+14.2%$992.07M$117.61M51.00450PRAXPraxis Precision Medicines2.9278 of 5 stars$47.90+2.0%$85.88+79.3%-24.1%$987.89M$8.55M-3.90110News CoveragePositive NewsAnalyst ForecastNUVBNuvation Bio2.525 of 5 stars$2.98+3.4%$7.33+146.3%+13.8%$985.75M$7.87M-4.7360News CoveragePHARPharming Group2.9318 of 5 stars$13.55-5.1%$30.00+121.3%+99.3%$978.39M$297.20M-104.26280News CoveragePositive NewsShort Interest ↓Gap DownMLYSMineralys Therapeutics1.6638 of 5 stars$15.11+2.5%$32.25+113.4%+180.2%$977.19MN/A-4.2428News CoverageAnalyst ForecastORICOric Pharmaceuticals4.7095 of 5 stars$9.85+2.4%$17.63+78.9%+12.3%$934.32MN/A-5.2180News CoveragePositive NewsAnalyst ForecastIOVAIovance Biotherapeutics4.5071 of 5 stars$2.45-3.2%$11.90+385.7%-79.0%$915.49M$164.07M-1.99500Gap Down Related Companies and Tools Related Companies CorMedix Competitors atai Life Sciences Competitors Spyre Therapeutics Competitors Cronos Group Competitors Praxis Precision Medicines Competitors Nuvation Bio Competitors Pharming Group Competitors Mineralys Therapeutics Competitors Oric Pharmaceuticals Competitors Iovance Biotherapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JBIO) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jade Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jade Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JBIO Stock Alerts